Clinical Scorecard: Identification of a New WDR26 Variant in a Chinese Child with Skraban-Deardorff Syndrome: A Case Study and Review of Existing Literature
At a Glance
Category
Detail
Condition
Skraban-Deardorff syndrome
Key Mechanisms
De novo variants of the WDR26 gene leading to haploinsufficiency
Target Population
Pediatric patients with neurodevelopmental disorders
Care Setting
Pediatric healthcare facilities
Key Highlights
Skraban-Deardorff syndrome is an extremely rare autosomal dominant neurodevelopmental disorder.
Clinical features include intellectual disability, developmental delays, seizures, and abnormal facial characteristics.
A novel heterozygous frameshift variant c.271delA (p.Thr91Profs*40) of the WDR26 gene was identified.
Delayed language development is a typical clinical phenotype, with no major reports of epilepsy in the Chinese population.
Timely language interventional therapy is crucial for improving prognosis.
Guideline-Based Recommendations
Diagnosis
Genetic testing for WDR26 variants is recommended for suspected cases.
Management
Comprehensive rehabilitation training including physical and speech therapy.
Monitoring & Follow-up
Regular neurodevelopmental assessments and imaging studies as needed.
Risks
Delayed language development may significantly compromise prognosis if not addressed.
Patient & Prescribing Data
Children diagnosed with Skraban-Deardorff syndrome.
Management focuses on rehabilitation therapies; no straightforward treatment for language delays.
Clinical Best Practices
Early intervention with physical and speech therapy is essential.
Regular follow-up and monitoring of developmental milestones.
